vIL-6 |
K2 |
Constitutively activate gp130 independently of IL-6R; B cell proliferation; auto/paracrine growth factors; angiogenic
|
Productive |
vCCL1 |
K6 |
CCR5 and CCR8 agonists; chemoattraction of Th2 cells and monocytes; angiogenic
|
Productive |
vCCL2 |
K4 |
CCR3 and CCR8 agonists; chemoattraction of Th2 cells and monocytes; angiogenic
|
Productive |
vCCL3 |
K4.1 |
CCR4 agonist; chemoattraction of Th2 cells; induction of VEGF-A and angiogenesis
|
Productive |
vIAP |
K7 |
Inhibitor of apoptosis; inhibition of vGPCR expression and function |
Productive |
vBcl-2 |
ORF16 |
Inhibition of Bax-mediated and virally induced apoptosis |
Productive |
vIRF1 |
K9 |
Transformation; inhibition of p300, p53, and TGF-β; inhibition of type I interferon |
Productive |
vIRF2 |
K11.5 |
Inhibition of type I interferon and NF-kB; inhibition of Fas-mediated apoptosis via inhibition of CD95L expression |
Productive |
LANA-2 |
K10.5 |
Inhibition of type I interferon production; inhibition of PKR- and caspase 3-mediated apoptosis |
Productive |
vIRF3 |
K10.6 |
Inhibition of p53 and NF-kB; inhibition of Fas-mediated apoptosis via inhibition CD95L expression |
Productive |
vFLIP |
K13/ORF71 |
Transactivator of NF-kB; antiapoptotic activity via FADD and TRADD binding; transformation
|
Latent |
|
vCyclin |
ORF72 |
|
|
|
Constitutively activate Cdk6; resistant to Cdk inhibitors, destabilizes p27 |
Latent |
vOX-2 |
K14 |
Downregulation of myeloid cell activation; regulation of inflammatory cytokine production (IL-1β, TNF-α, IL-8, IFN-γ, and IL-6) |
Productive |
vGPCR |
ORF74 |
Constitutively active; induces VEGF secretion; transformation
|
Latent/productive |